Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
At ZohoDay 2026, Newcross Healthcare showcased how it built a mission‑critical care‑management application on Zoho’s governed platform, unifying CRM, finance, workforce and analytics. By leveraging Zoho Creator, the team delivered a fully integrated solution in six months, cutting licensing costs to roughly £35 per user. The architecture emphasizes trusted, real‑time data flows and AI augmentation through Zoho’s Zia, rather than relying on generic LLMs. This approach highlights the strategic value of disciplined platform design over AI hype in high‑stakes healthcare environments.
Cardiovascular disease remains the top global killer, accounting for 19.8 million deaths in 2022, with 85% linked to myocardial infarction or stroke. Echocardiography is essential for detecting ischemic cardiomyopathy, wall‑motion abnormalities, and left‑ventricular remodeling. Coronary artery bypass grafting (CABG) is a...
February 2026 saw a surge of biosimilar activity, with key regulatory approvals for products such as Sandoz Enzeevu (Eylea), Accord Filkri (Neupogen), and STADA Gotenfia (Simponi) across the US, Canada and the EU. Companies forged new licensing and commercialization deals that extend biosimilar...
Quell Therapeutics has launched the phase 1/2 CHILL trial of its autologous CAR‑Treg therapy QEL‑005 in rheumatoid arthritis and systemic sclerosis, after pausing the liver‑transplant program QEL‑001. The multi‑center study will enroll patients in the UK, Germany and Spain, with read‑out...
NHS England has set a firm deadline to retire the CIS1 authentication service, removing access on 28 February 2027 after reducing its SLA to silver on 1 October 2025. The move forces NHS trusts and other European hospitals to adopt the newer CIS2 platform,...
RecovryAI, emerging from stealth, received FDA Breakthrough Device Designation for its physician‑prescribed Virtual Care Assistants (VCAs), AI tools that guide patients through post‑operative recovery. The designation, reserved for devices that can substantially improve care standards, accelerates the company’s engagement with...
In this episode, Bruno Quinney highlights four major developments: a long‑acting injectable HIV regimen (cabotegravir + rilpivirine) that cut virological failure risk by nearly half versus daily oral therapy; SolasCure’s ORES wound gel, which accelerated debridement 22‑fold and healing seven‑fold in chronic...
![Balancing the Role of Physicians and AI [Video]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://medcitynews.com/wp-content/uploads/sites/7/2026/03/Smarter-Technologies_2.00_00_19_17-1024x576.png)
At the ViVE conference, Smarter Technologies’ chief medical officer Ruben Amarasingham highlighted the firm’s AI strategy aimed at improving data accuracy while easing physicians’ documentation load. He cited positive customer feedback that the platform reduces administrative burden and delivers clear...
Cigna announced that long‑time CEO David Cordani will retire on July 1, 2026, and be succeeded by internal candidate Brian Evanko, the current president and chief operating officer. Cordani, who will remain board chair, has led the firm for 17 years,...
Lynk Pharmaceuticals announced topline Phase III data for its oral JAK inhibitor zemprocitinib in 356 patients with moderate‑to‑severe atopic dermatitis. Both the 12 mg and 24 mg doses met the co‑primary endpoints at week 16, delivering 38‑46 percentage‑point improvements in EASI‑75 and roughly 30 percentage‑point gains...
The GAO report reveals that, despite a conditional approval pathway introduced in 2004 and expanded in 2018, FDA‑approved animal drugs for minor species and niche uses remain scarce. From FY2018 through FY2025, only 13 drugs received conditional approval, all targeting...
New reporting from me taking you inside the $QURE - FDA Huntington's gene therapy imbroglio. I spoke to a senior FDA official late yesterday, who told me agency reviewers "are not convinced there’s any therapeutic benefit of the product. If...
The FDA concluded that UniQure’s experimental gene therapy for Huntington’s disease has not demonstrated therapeutic benefit based on existing clinical data. Reviewers said they are not persuaded by the evidence, prompting the agency to block the company from submitting a...
The anti‑ageing skin‑care conference introduced the concept of biodesynchronosis, framing skin ageing as a loss of regulatory coordination rather than merely chronological time. Speakers argued that traditional markers like wrinkles miss upstream failures, and that recovery speed after stress better...
Alzheimer’s research is increasingly looking beyond plaques and tangles to the brain’s immune response. A study published in Elsevier's Pharmacological Research journal used AI to screen 1.6M compounds for a Galectin-3 (Gal-3) blocker that could cross the brain barrier. In Alzheimer’s-like...
Senators John Boozman (R‑AZ) and Gary Peters (D‑MI) have introduced a bipartisan bill to extend Veterans Affairs burial benefits to veterans who die in hospice or other non‑VA health settings. The legislation builds on the 2023 Dole Act expansion, which...
The essay examines how Jewish law’s reliance on legal fictions clashes with modern end‑of‑life medicine. It contrasts Halakha’s categorical certainty—viewing every moment of life as sacred—with medicine’s humility that prioritizes patient comfort and informed choice. While some rabbinic authorities allow...
At a ViVE conference, CIOs from Christus Health, SSM Health and HCA Healthcare warned that variability, not scale, is the primary cost driver for large health systems. They highlighted governance gaps that allow endless project approvals but few rejections, leading...
In this episode, St. James Hospital Dublin’s Chief Data Officer Guido Giunti explains why AI transformation in healthcare must begin with AI and data literacy across all staff, not just technology deployment. He describes a blended top‑down and bottom‑up strategy that uses...
Dr. Tessa Cook, an associate professor and vice chair of practice transformation in radiology at Penn Medicine, discusses how her team approaches clinical AI implementation. She emphasizes a systematic, "set it and forget it" mindset is unrealistic; instead, AI tools...
Jacksonville‑based startup MMI is preparing the first U.S. microrobotic surgeries to treat Alzheimer’s by clearing lymphatic drainage pathways in the neck. The FDA granted clearance for an initial safety cohort of 15 patients, with five slated for the first procedure...
Innovent’s pirtobrutinib, marketed as Jaypirca, received Chinese NMPA approval for adults with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma who have undergone at least one prior therapy, including a BTK inhibitor. The decision follows the phase‑III BRUIN CLL‑321 trial,...
A recent analysis of 6,069 cognitively normal women examined whether epigenetic aging clocks predict incident mild cognitive impairment or dementia. Second‑ and third‑generation clocks (AgeAccelPheno, AgeAccelGrim2, DunedinPACE) were compared with first‑generation Horvath and Hannum measures. Only the AgeAccelGrim2 clock showed...
InterSystems and Resilience Care have formed a technology partnership to integrate Resilience Care’s remote‑monitoring platform with InterSystems IRIS for Health, streamlining oncology care pathways. The integration layer connects hospital information systems, automates data exchange for chemotherapy, lab, and imaging appointments,...
The U.S. Centers for Medicare & Medicaid Services (CMS) has pushed back the deadline for manufacturers to join its GENEROUS pilot, extending the initial cut‑off to April 30 while keeping the final deadline at June 30. The voluntary program applies a Most‑Favoured...
Eight leading European microphysiological systems companies have launched the Industry Alliance for Microphysiological Systems (IAMPS), the world’s first trade association dedicated to MPS technologies. IAMPS will represent organ‑on‑chip, organoid and related NAM developers, aiming to harmonize standards, promote data sharing,...
Merck and Eisai disclosed Phase III LITESPARK-011 results showing that the oral combination of Welireg (belzutifan) and Lenvima (lenvatinib) outperformed cabozantinib in 747 patients with advanced renal cell carcinoma who progressed after anti‑PD‑1/PD‑L1 therapy. At a median follow‑up of 29...
I remember what it was like to study the heart from textbooks and medical atlases. This video demonstrates how different the experience could be with mixed reality. It could lead to a new level of understanding of anatomy and pathology. The...
Isla Health’s new whitepaper outlines how NHS trusts can digitise PSA surveillance to cut unnecessary urology follow‑ups. By automating data capture, trusts can process patients 87% faster and slash administrative work by up to 80%, freeing clinical nurse specialists for...
Dermatology research is booming, with more than 16,000 trials completed, ongoing, or planned by the end of 2025. The Asia‑Pacific region now hosts roughly 8,000 studies, a five‑fold increase over the past decade, matching North America and Europe combined. Low...
East Cheshire NHS Trust announced five strategic aims for 2026 following a smoother‑than‑expected Meditech EPR go‑live in June 2025. The plan includes a major system upgrade in March, digitising the top 50 high‑priority clinical documents, and expanding internal referral orders...
The article highlights persistent low‑tech practices in 2026 healthcare—mis‑timed pharmacy texts, imaging still sent on physical CDs, and reliance on fax—while executives chase AI. It shows that simple fixes are known but remain unfixed due to cultural and governance gaps....
How to use ChatGPT as a doctor (properly) Not for diagnosis. Not to replace your brain. Use it to: • Simplify complex topics for patients • Draft patient education handouts • Create clinic SOPs • Generate content ideas • Structure research summaries • Prepare presentations • Improve communication clarity Think of...
T-cell engagers for autoimmunity. Listen to Ken Song describe the opportunity as CEO of San Diego-based Candid Therapeutics. Sponsored by @AlphaSenseInc & Dash Bio. https://t.co/Ct2viH00c4
In January, twin brothers with measles were treated at Mission Hospital in Asheville, North Carolina, but staff failed to isolate them for over four hours, exposing at least 26 other patients. A CMS investigation placed the hospital in Immediate Jeopardy,...
What is the diagnostic yield of MRI in adult emergency patients with dizziness or vertigo? While MRI is efficient for detecting central causes of dizziness, its yield is low in cases of isolated dizziness without neurological signs. 👇 https://t.co/170qBbHrq7
In this episode, Othman Laraki, CEO of Color, recounts the company’s three major pivots—from a cancer genetics startup to its current health‑tech platform—highlighting the financial, team, and market challenges each transition entailed. He stresses that while technology and product are...
Researchers demonstrated that a clinically‑available 1.5 T static magnetic field can trigger the release of encapsulated molecules from magnetoliposomes (MLs). The study used citric‑acid‑stabilized Fe₃O₄ nanoparticles, with and without a chitosan coating, and monitored structural changes via SAXS and DLS. Fluorescence...
Earlier this year the UK government pledged £82.6 million to AI‑focused drug‑discovery firms, underscoring its ambition to lead the global digital health transformation. Major players such as AstraZeneca are launching dedicated health‑tech units like Evinova to accelerate clinical‑trial design, while the...
Telehealth’s rapid expansion has left older adults behind because most platforms ignore age‑related cognitive, sensory, and usability challenges. Studies show that while over half of seniors are interested in video visits, only a third feel comfortable using them, highlighting a...
@PBS: Five things to consider before asking a chatbot for health advice (by @AP_FDAwriter). Among them: ask two different AIs and see if they agree; don't stay home if you have red flag symptoms like chest pain, shortness of breath....
Proscia has been crowned the top‑performing digital pathology software vendor in the United States, receiving a 95.2 overall score in KLAS Research’s 2026 report and earning A+ or A grades across all six customer‑experience pillars. The company is also the...
After a wave of senior departures and a 3,500‑position cut, the FDA entered 2026 with a largely inexperienced workforce, raising uncertainty for drug developers. The agency’s new AI guidance, released in January, outlines best practices but emphasizes human oversight and...
I’ll be joining a Zoom discussion hosted by Roon on March 5, 1:30-2:30 ET. We'll discuss how clinicians are using AI in actual practice and the implications. I'll be joined by 3 eminent colleagues: Mandy Cohen, Sara Murray, & Spencer...
Hands‑on medical assistant programs, like Allen School’s, immerse students in real‑clinic environments, letting them practice patient interviews, vital‑sign collection, and equipment use under supervision. Repeated simulations of appointment flow, teamwork, and electronic record entry turn theoretical knowledge into muscle memory...
A Pew Research survey of 2,582 U.S. adults aged 65 and older finds that 60% would rather stay at home with a caregiver if they can no longer live independently, while only 18% prefer moving to an assisted‑living community. Preference...
A University of Michigan study examined the impact of Michigan’s 2022 repeal of its universal motorcycle‑helmet law. Researchers found hospital costs rose by $5,785 per injured rider—a 26% increase—adding more than $4.5 million in annual expenses, or $6.4 million when adjusted to...
The U.S. Food and Drug Administration granted De Novo clearance to Ultrasound AI’s Delivery Date AI, a cloud‑based software‑as‑a‑medical‑device that predicts a pregnant woman's delivery date using only standard ultrasound images. The model was trained on more than one million...
A new JMIR Dermatology study finds TikTok is the primary education source for patients with hidradenitis suppurativa (HS) in skin of color. Researchers analyzed 50 videos and discovered that nearly half were patient‑generated, while only about 20% featured dermatologists. Physician‑authored...
908 Devices reported Q3 2025 revenue of $14 million, a 4% year‑over‑year decline but an 8% sequential increase, driven largely by FTIR‑based Explorer devices. Adjusted EBITDA loss narrowed to $1.8 million, a 53% quarter‑over‑quarter improvement, marking the smallest loss since the company...
